Cryptococcosis: Case reports, epidemiology and treatment options;Kryptokokkose: Kasuistiken, Epidemiologie und Therapiestrategien

Deutsche Medizinische Wochenschrift

Volumn 138, Issue 30, 2013, Pages 1533-1538

  Mischnik, A ^a   Klein, S ^a   Tintelnot, K ^b   Zimmermann, S ^a   Rickerts, V ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

cryptococcosis; Cryptococcus; meningoencephalitis; treatment

Indexed keywords

CASE REPORT; CRYPTOCOCCOSIS; HUMAN; REVIEW;

ANTIFUNGAL AGENTS; CRYPTOCOCCOSIS; DISEASE OUTBREAKS; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME;

EID: 84880436470     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0033-1343285     Document Type: Review

References (25)

1. Bratton E. W., El Husseini N., Chastain C. A. et al. Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplant. PLoS One: 2012; 7 e43582
2. Brouwer A. E., Rajanuwong A., Chierakul W. et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet: 2004; 363 1764 1767 (Pubitemid 38698379)
3. Byrnes E. J. 3rd, Bartlett K. H., Perfect J. R. et al. Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals. Microbes Infect: 2011; 13 895 907
4. Currie B. P., Freundlich L. F., Soto M. A. et al. False-negative cerebrospinal fluid cryptococcal latex agglutination tests for patients with culture-positive cryptococcal meningitis. J Clin Microbiol: 1993; 31 2519 2522 (Pubitemid 23254231)
5. Dromer F., Mathoulin-Pelissier S., Launay O. et al. Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS Med: 2007; 4 e21
6. Firacative C., Trilles L., Meyer W. MALDI-TOF MS enables the rapid identification of the major molecular types within the Cryptococcus neoformans/C. gattii species complex. PLoS One: 2012; 7 e37566
7. French M. A., Price P., Stone S. F. Immune restoration disease after antiretroviral therapy. AIDS: 2004; 18 1615 1627 (Pubitemid 39095778)
8. Hagen F., Colom M. F., Swinne D. et al. Autochthonous and Dormant Cryptococcus gattii Infections in Europe. Emerg Infect Dis: 2012; 18 1618 1624
9. Jarvis J. N., Bicanic T., Harrison T. S. Management of cryptococcal Meningoencephalitis in both developed and developing countries. In: Heitman J., Kozel T. R., Kwon-Chung KJ. et al., eds. Cryptococcus: From human pathogen to model yeast. Washington ASM press: 2011; Chapter 42
10. Jarvis J. N., Percival A., Bauman S. et al. Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clin Infect Dis: 2011; 53 1019 1023
11. McTaggart L. R., Lei E., Richardson S. E. et al. Rapid identification of Cryptococcus neoformans and Cryptococcus gattii by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol: 2011; 49 3050 3053
12. Messer S. A., Moet G. J., Kirby J. T. et al. Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007). J Clin Microbiol: 2009; 47 1942 1946
13. Pappas P. G., Perfect J. R., Cloud G. A. et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis: 2001; 33 690 699 (Pubitemid 32762943)
14. Park B. J., Wannemuehler K. A., Marston B. J. et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS: 2009; 23 525 530
15. Perfect J. R., Dismukes W. E., Dromer F. et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis: 2010; 50 291 322
16. Perfect J. R., Marr K. A., Walsh T. J. et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis: 2003; 36 1122 1131 (Pubitemid 36549632)
17. Pitisuttithum P., Negroni R., Graybill J. R. et al. Activity of posaconazole in the treatment of central nervous system fungal infections. J Antimicrob Chemother: 2005; 56 745 755 (Pubitemid 41487778)
18. Powderly W. G., Saag M. S., Cloud G. A. et al. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. N Engl J Med: 1992; 326 793 798
19. Robert Koch-Institut Epidemiologie der Kryptokokkose in Deutschland von 2004 bis 2010. Epidemiologisches Bulletin: 2012; 29 275 278
20. Schulze K., Schmiedel S., van Lunzen J. [Immune reconstitution inflammatory syndrome in cryptococcal meningitis: a rare phenomenon?]. Dtsch Med Wochenschr: 2012; 137 834 837
21. Singh N., Lortholary O., Alexander B. D. et al. An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis: 2005; 40 1756 1761 (Pubitemid 40799944)
22. Sun H. Y., Alexander B. D., Lortholary O. et al. Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients. Clin Infect Dis: 2010; 51 1062 1069
23. Sungkanuparph S., Filler S. G., Chetchotisakd P. et al. Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study. Clin Infect Dis: 2009; 49 931 934
24. Tintelnot K., Adler S., Bergmann F. et al. Case reports. Disseminated cryptococcoses without cryptococcal antigen detection. Mycoses: 2000; 43 203 207 (Pubitemid 30642823)
25. van der Horst C. M., Saag M. S., Cloud G. A. et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med: 1997; 337 15 21